# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006353
Filing Date
2022-03-09
Accepted
2022-03-09 08:01:02
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2257008
2 |  | ex4-6.htm | EX-4.6 | 22317
3 |  | ex21-1.htm | EX-21.1 | 1251
4 |  | ex23-1.htm | EX-23.1 | 2669
5 |  | ex31-1.htm | EX-31.1 | 10970
6 |  | ex31-2.htm | EX-31.2 | 10777
7 |  | ex32-1.htm | EX-32.1 | 3494
8 |  | ex32-2.htm | EX-32.2 | 3530
9 |  | chart_1.jpg | GRAPHIC | 44466
10 |  | form10-k_004.jpg | GRAPHIC | 129807
11 |  | form10-k_005.jpg | GRAPHIC | 16301
12 |  | form10-k_006.jpg | GRAPHIC | 13739
13 |  | form10-k_007.jpg | GRAPHIC | 14195
14 |  | form10-k_008.jpg | GRAPHIC | 146009
15 |  | form10-k_009.jpg | GRAPHIC | 34964
16 |  | form10-k_010.jpg | GRAPHIC | 29179
17 |  | form10-k_011.jpg | GRAPHIC | 86766
18 |  | form10-k_012.jpg | GRAPHIC | 47543
| Complete submission text file | 0001493152-22-006353.txt |  | 9649537

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | XBRL SCHEMA FILE | lpcn-20211231.xsd | EX-101.SCH | 47648
20 | XBRL CALCULATION FILE | lpcn-20211231_cal.xml | EX-101.CAL | 68548
21 | XBRL DEFINITION FILE | lpcn-20211231_def.xml | EX-101.DEF | 207736
22 | XBRL LABEL FILE | lpcn-20211231_lab.xml | EX-101.LAB | 426405
23 | XBRL PRESENTATION FILE | lpcn-20211231_pre.xml | EX-101.PRE | 335060
82 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1331463

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36357 | Film No.: 22723954
SIC: 2834 Pharmaceutical Preparations